Kymera Therapeutics

Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.



Post IPO Equity




Org chart

Nello Mainolfi
Co-Founder, President & CEO
Jared Gollob
Chief Medical Officer
Ellen Chiniara
Chief Legal Officer & Corporate Secretary
Ashwin Gollerkeri
SVP & Head of Development
Juliet Williams
SVP & Head of Biology
Brian Albarran
SVP, Corporate Strategy
Kevin Dushney
SVP, IT & Operations
Todd Cooper
SVP, Corporate Affairs
Vijay Sabesan
SVP, Technical Operations
Karen Weisbach
VP, People & Culture
Jolly Bhatia
VP, Quality
Aimee Mishkin
VP, Regulatory Affairs
Melissa Brody
VP, Business Development
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.